Ustekinumab versus adalimumab for induction and maintenance therapy in biologic-naive patients with moderately to severely active Crohn's disease: a multicentre, randomised, double-blind, parallel-group, phase 3b trialBruce E. Sands, Olga Fedorishina, Long-Long Gao et al.|The Lancet|2022Cited by 295
Ecological correlates of risk and incidence of West Nile virus in the United StatesBrian F. Allan, Jonathan M. Chase, R. Brian Langerhans et al.|Oecologia|2008Cited by 250